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Abstract
Genito-urinary tract or systemic infections of the gram-negative bacteria in pregnant women, causes abortions, preterm
labor, and several other perinatal complications. LPS is the most potent antigenic component of the gram-negative bacterial
cell wall and is known to modulate the expression of various proinﬂammatory cytokines. Here we investigate the role of the
soluble form of IL-1 i.e., IL-1b in the ‘minimum dose’ of LPS induced pregnancy loss in mice. Uterine cross-sections on
each day of the preimplantation period of pregnancy were examined histopathologically for ﬁnding out LPS induced changes
in the uterine preparation for embryo implantation. The expression of IL-1b in the various stages of the preimplantation
period of pregnancy was studied by RT-PCR in the embryos and the uterine horns of the LPS treated and normal pregnant
mice. We found that LPS signiﬁcantly alters the proliferation of the glandular epithelium, luminal epithelium and stroma
during the preimplantation period. We also found large inﬁltration of macrophages into the uterine horns of the LPS treated
animals. The level and pattern of IL-1b expression in the preimplantation embryos and uterine horns were also altered in
LPS treated animals. These observations indicate that LPS can alter the uterine preparation for blastocyst implantation,
which could be due to the change in the IL-1b expression in the uterine horns. However, a change in the expression pattern
of IL-1b in the preimplantation embryos underlines the signiﬁcance of this molecule in LPS induced pregnancy loss or
implantation failure in mouse.
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Introduction
Many of the reported actions of cytokines are
clearly related to combating bacterial infections
[1]. During gram-negative bacterial infections bac-
terial lipids can be easily recognized by the host
immune system because they are structurally
distinct from mammalian cell lipids. Mononuclear
phagocytes express a cell surface receptor that can
recognize many such foreign lipids, particularly
those derived from the cell walls of gram-negative
bacteria, collectively called endotoxin or lipopoly-
saccharide (LPS) (for a review see [2]). LPS is the
most potent antigenic component of the gram-
negative bacterial cell wall. Genital tract infection/
vaginitis caused by Gram-negative bacteria is one of
the major causes of gynecologic morbidity, such as
infertility, ectopic pregnancy, preterm labor and
chronic pelvic pain [3,4]. Beside this, systemic
gram-negative bacterial infections like typhoid fever
caused by Salmonella typhi, during pregnancy can
cause several perinatal complications and preterm
labor. Activated mononuclear phagocytes secrete
chemokines and proinﬂammatory cytokines like IL-
1, IL-6, TNF etc. that function in the recruitment
of blood monocytes and neutrophils to the local site
of inﬂammation. Proinﬂammatory cytokines like IL-
1, TNF etc., are secreted by a wide variety of cells
during a pathogenic response. Interleukin-1 was
initially discovered as a protein capable of inducing
pyrexia (endogenous pyrogens). Thus, most of the
proinﬂammatory cytokines are known as pyroxenes,
and the increase in core temperature that they
induce may promote the antibacteial activity of
leukocytes [5].
Interleukin-1 (IL-1) is an immunoregulatory
cytokine with several functions, including stim-
ulation of T lymphocyte, cytokine production,
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and initiation of the inﬂammatory cytokine cascade
[6]. The two forms of IL-1, IL-1a and IL-1b, have
similar biological activities, but are distinct peptides,
encoded by separate genes. The molecular weight of
both the forms of IL-1 protein is 17 kDa., which
show *26% sequence homology, bind to the same
receptor (i.e., IL-1RI) and mediate similar actions.
IL-1b is the predominant form of IL-1 that is
produced by most cells and is secreted as a soluble
form. IL-1 causes the rapid induction of a wide
variety of genes that encode for proinﬂammatory
proteins and cytokines.
Although incompletely deﬁned, it is clear that a
number of molecules including growth factors,
cytokines, prostaglandins (PGs), histamine, platelet
activating factors and various other molecules have
been implicated in the process of implantation [7],
which, render the uterus receptive and directs the
embryo-uterine interactions to initiate the process of
implantation [8]. Cytokines produced by the devel-
oping embryo and the maternal endometrium
include leukemia inhibitory factor [9], interleukin
[10,11], hepatocyte growth factor [12], stem cell
factor [13,14], macrophage colony stimulating
factor [15], insulin like growth factors [16], tumor
necrosis factor [17] etc. However, the actual
function of these cytokines in implantation is not
well understood. The implantation process is
described as an inﬂammatory reaction and it is
proposed that there exists a deﬁned pattern and level
of expression of these proinﬂammatory molecules at
the feto-maternal interface. Any disturbance in this
delicate immune balance can lead to implantation
failure or pregnancy loss.
In a previous study we found that a single dose of
5 mg LPS/ animal (given i.p. on day-0.5 of preg-
nancy) was the ‘‘minimum dose’’ (MD) required to
cause total implantation failure in mice [18]. We
have also seen that high levels of LPS induced IL-1a
cause implantation failure in mice [18]. In this study
we tried to determine the role of the secreted form of
IL-1 i.e., IL-1b in preimplantation embryonic
development and LPS induced implantation failure
in mice. Since LPS is know to modulate the
expression of IL-1a in preimplantation embryos
and uterine horns, leading to implantation failure
[18], we were interested to study its effect on the
level and pattern of expression of IL-1b too.
Histopathological analyses of the uterine cross
sections obtained from animals treated with the
MD of LPS were carried out to ﬁnd out its
pathogenic effects on the uterine preparation for
implantation. Our studies indicate that both the
soluble and membrane bound forms of IL-1 are




Park strain mice (6–7 wks, 20 g) were maintained at
258C in our animal house with 12:12 h light: dark
schedule. They were fed with pelleted diet (Amrut
India Pvt. Ltd, New Delhi, India) and water ad
libitum. Sexually matured female animals with
normal estrus cycles were checked for proestrous
and were individually caged overnight with proven
fertile males for mating. The females were checked
for vaginal plugs on next day morning. Females with
positive vaginal plugs were considered as on day half
(day 0.5) of pregnancy.
Histopathology
The histopathological analysis of uterine horns was
carried out according to a standard procedure. The
small portions of recovered uteri from pregnant
animals of each groups were dissected out, freed
from fat bodies and ﬁxed in buffered formalin for
24 h. Tissues were dehydrated in graded series of
ethanol, cleared in xylene, inﬁltrated and embedded
in parafﬁn wax at 608C. The blocks were sectioned at
8 mm using a microtome (Leica, Germany). The
tissue sections were stained with Haematoxylin and
Eosin solutions, observed under a microscope
(Nikon, Japan) using 10X and 40X objectives and
photographed.
The cross sections of uterine horns were checked
for the presence of mitotic bodies and macrophages.
The number of mitotic bodies per 100 nuclei was
counted according to Finn et al. (1995) [19]. The
distribution of macrophages in uterine sections
were quantitated by counting their numbers per
40X view ﬁeld under the microscope according to
Bagavandoss et al. (1990) [20].
Histopathological analysis of uterine horns at different
stages of preimplantation period of pregnancy in animals
treated with the ‘minimum dose’ of LPS on day-0.5 of
pregnancy
The present study was conducted to analyze the LPS
induced alterations in the uterine horns of pregnant
animals during the different stages of preimplanta-
tion period of pregnancy. The pregnant females were
divided into 5 groups i.e., (Group I, II, III, IV and V)
of 6 animals each. Three pregnant animals of each
group received single i.p. injection of the ‘minimum
dose’ of LPS on day-0.5 of pregnancy. The remain-
ing three pregnant animals in each group (i.e.,
control) received 100 ml of sterile normal saline in a
similar fashion. All animals of Group I, II, III, IV and
V were killed by cervical dislocation on days 0.5
(after 2 h of treatment), 1.5, 2.5, 3.5, and 4.5 of
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immediately processed as described earlier for
histopathological examinations.
Superovulation and embryo recovery at different time
points
The female mice (6–7 wks, 20 g) were induced to
superovulate with i.p. injections of 5 IU each of
PMSG and hCG (Intervet, Holland) at an interval of
48 h. Twenty to 25 superovulated pregnant animals
were sacriﬁced, at each time, by cervical dislocation,
at different time points through days 0.5 to 4.5 (days
1.5, 2.5, 3.5, 4.0, 4.125, 4.25, 4.33, and 4.42) of
pregnancy. About 500 embryos/group were recov-
ered, from these animals at each time point/day of
pregnancy, by ﬂushing the excised reproductive
tracts with sterile PBS. They were immediately
frozen and stored at 7708C for isolation of total
RNA. The uterine horns of the animals were
immediately processed for total RNA isolation.
Effect of LPS on expression of IL-1b in embryos and
uterine horns collected at different stages of
preimplantation period of pregnancy
Experiments were performed to study the effect of
LPS on the expression of IL-1b in embryos and
uterus collected at different stages of preimplantation
period (i.e., days 1.5, 2.5, 3.5, 4.0, 4.125, 4.25, 4.33,
and 4.42) of pregnancy by RT-PCR. Park strain
mice (6–7 weeks) were superovulated with PMSG
and hCG as per the protocol mentioned earlier. The
‘minimum dose’ of LPS (i.e., 5 mg/animal) in 100 ml
of sterile normal saline (determined in previous
study) was injected to each pregnant animal through
i.p. route on day-0.5 of pregnancy. The control
animals received 100 ml of sterile normal saline in a
similar manner. The animals of both groups were
sacriﬁced at narrow intervals of the preimplantation
period (i.e., days-1.5, 2.5, 3.5, 4.0, 4.125, 4.25, 4.33,
and 4.42) of pregnancy to collect the embryos and
uterine horns. A total of about 500 embryos were
collected at each time to detect the positive mRNA
signals for IL-1b by RT-PCR.
Preparation of total cellular RNA from embryos collected
at different stages of preimplantation period of pregnancy
A total of 500 preimplantation (2-cell to blastocyst
stage) stage embryos were collected after super-
ovulation and resuspended in 200 ml of sterile PBS.
The collected embryos were directly used for
extraction of total cellular RNA using the ‘‘High
Pure RNA Isolation Kit’’ (Boehringer Mannheim,
Germany). RNA was isolated as per the instructions
provided by the manufacturer and was ﬁnally eluted
in 60 ml of elution buffer. 15 ml of each extract was
used for every reaction of RT-PCR.
Extraction of total cellular RNA from uterine horns
collected at different stages of preimplantation period of
pregnancy
Total RNA was extracted from uterine horns
collected from control and LPS treated pregnant
animals by a using the guanidium isothiocyanate-
phenol chloroform method [21]. The animals were
sacriﬁced by cervical dislocation and uterine horns
were removed quickly, washed with chilled normal
saline (0.9% NaCl), cleaned, blotted dry and
weighed. About 100 mg of the tissue was used for
total RNA isolation at each time. The concentration
of total cellular RNA was estimated at A260 (1
A260=40mg of RNA) and was stored at –208C for
further studies. The quality of the RNA was checked
by agarose gel (1%) electrophoresis. Ten micrograms
of the extracted RNA was used for each reaction of
RT-PCR.
Reverse Transcription-Polymerase Chain Reaction
(RT-PCR)
The reverse transcription polymerase chain reaction
(RT-PCR) was carried out using ‘‘Titan
TM One tube
RT-PCR System’’ (M/S Boehringer Mannheim,
Germany). It was carried out as per the instructions
provided by the manufacturer. AMV reverse tran-
scriptase was used in the reaction to synthesize the
ﬁrst strand of DNA and an enzyme blend of Taq
DNA polymerase and Pow DNA polymerase was
used for second strand synthesis and for subsequent
steps of PCR. One micrlitre of the 4 dNTP mix
(10 mM each dNTP; MBI Fermentas, Lithuania,
ﬁnal concentration 0.2 mM each dNTP) and 1 ml
each of the upstream and downstream primers
(20 mM stock, Clontech USA) and total RNA extract
were added to a total reaction volume of 50 ml. This
was overlaid with 50 ml of mineral oil.
The upstream and downstream primers for IL-1b
were initially purchased from M/S Clontech USA,
and later synthesized from M/S Genset Singapore
Biotech Pte. Ltd. Singapore. The primers for b-actin
were synthesized from M/S Genset Singapore
Biotech Pte. Ltd. Singapore and were used as
internal control throughout the experiments [22].
The primers used were: 5’-ATGGCAACTGTTCC
TGAACTCA ACT-3’ plus 5’-CAGGACAGGTA-
TAGATTCTTTCCTTT-3’ for IL-1b and 5’-
GGGCACAGTGTGGGTGAC-3’ plus 5’-CTGG-
CACCACACCTTCTAAC-3’ for b-actin.
One round of RT was carried out in a thermo-
cycler (MJ Research, USA) equilibrated at 508C for
30 min, which was followed by an initial denatura-
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cycles of PCR. In each cycle of PCR the denatura-
tion was carried out for 1 min at 948C, annealing
was carried out for 1 min at 608C and elongation
was carried out for 2 min at 688C and elongation was
carried out for 2 min at 688C. Finally the samples
were elongated for 7 min at 688C and then stored at
48C till further use. The RT-PCR products were
conﬁrmed by sequencing.
Results
Histopathological analysis of uterine horns at different
stages of the preimplantation period of pregnancy in
animals treated with the ‘minimum dose’ of LPS on day
0.5 of pregnancy
The pregnant animals were treated with the ‘mini-
mum dose’ of LPS on day-0.5 of pregnancy and
histopathological alterations that occur in the uterine
horns were monitored on different stages of the
preimplantation period of pregnancy (i.e., from day-
0.5 to 4.5 of pregnancy). The changes observed on
each day of pregnancy were as follows:
Day-0.5 of pregnancy. The cross sections of uterine
horns from LPS treated animals showed hyperplasic
and degenerated luminal epithelium with a large
number of mitotic ﬁgures as compared to that of the
control. The glandular epithelium had also under-
gone hyperplasia. The stroma was highly vascularised
with a large number of inﬁltrating macrophages as
compared to that of the control (Figure 1a, b, and c).
However, degeneration of luminal epithelium and
hyperplasia in glandular epithelium were not ob-
served in cross sections of uterine horns from control
animals. Moreover, few macrophages were observed
in stroma of cross sections of uterine horns from
control animals (Figure 2a) as compared to the
treated animals (Figure 2b).
A large number of mitotic bodies were found in
luminal and glandular epithelium and in stroma of
cross sections of uterine horns from control and
treated animals. However, no signiﬁcant difference
in the number of mitotic bodies was observed
between the control and LPS treated animals.
Day-1.5 of pregnancy. The uterine sections from
LPS-treated animals showed highly hyperplasic
luminal epithelium with less number of mitotic
bodies (5+0.31 per 100 nuclei) as compared to
that of the control (15+0.948/100 nuclei). These
sections also showed degenerating glands with more
mitotic bodies in glandular epithelium (31+0.316
per 100 nuclei) as compared to that of the control
(26+1.87 per 100 nuclei) (Figure 1a, b and c). A
large number of scattered macrophages were also
Figure 1. (a) Effect of the ‘minimum dose’ of LPS on the number
of mitotic ﬁgures in luminal epithelium of uterus collected from
control and LPS treated animals during different stages of
preimplantation period of pregnancy. Means bearing similar
superscripted alphabets do not differ from each other at P
40.05. (b) Effect of the ‘minimum dose’ of LPS on the number
of mitotic ﬁgures in granular epithelium of uterus collected from
control and LPS treated animals during different stages of
preimplantation period of pregnancy. Means bearing similar
superscripted alphabets do not differ from each other at P
40.05. (c) Effect of the ‘minimum dose’ of LPS on the number
of mitotic ﬁgures in uterine stroma of uterus collected from control
and LPS treated animals during different stages of preimplantation
period of pregnancy. Means bearing similar superscripted alpha-
bets do not differ from each other at P 40.05.
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LPS treated animals as compared to that of the
control (Figure 2c and d).
A signiﬁcant decrease in the number of mitotic
bodies in the luminal epithelium of uterine sections
from treated animals was observed as compared to
that of the control (P50.05). However, the number
of mitotic bodies in glandular epithelium and stroma
of uterine sections from control and treated animals
did not differ signiﬁcantly.
Day-2.5 of pregnancy. The cross section of uterine
horns from LPS treated animals showed hyperplasic
luminal epithelium with no mitotic bodies and
degenerated glands with more mitotic nuclei (15
per 100 nuclei) in glandular epithelium as compared
to that of the control (8+0.96 per 100 nuclei)
(Figure 1a and b). The thickness of stroma was
reduced with more mitotic bodies (5+0.748 per
100 nuclei) as compared to the control (3+0.316
per 100 nuclei) (Figure 1c). A large number of
macrophages were observed in stroma and luminal
epithelial layer of treated animals as compared to that
of the control (Figure 2e and f).
A signiﬁcant decrease in number of mitotic bodies
in luminal epithelium of uterine sections from LPS
treated animals was observed as compared to that of
the control (P50.05). A signiﬁcant increase in
number of mitotic bodies was observed in glandular
epithelium and stroma of uterine sections from
treated animals as compared to that of the control
(P50.05).
Day-3.5 of pregnancy. The uterine sections from LPS
treated animals showed increase in epithelial thick-
ness and hyperplasic luminal epithelium as
compared to that of the control. No mitotic bodies
were observed in the luminal epithelium of cross
sections of uterine horns from treated animals as
compared to that of the control (6+0.748 mitotic
ﬁgures/100 nuclei) (Figure 1a). Moreover, mitotic
bodies were not observed in glandular epithelium of
treated animals as compared to that of the control
(2+0.244 per 100 nuclei) (Figure 1b). A hyperpla-
sic glandular epithelium was observed in treated
animals as compared to that of the control. A thick
and oedematous stroma was observed as compared
to uterine sections from treated animals on day-2.5
of pregnancy. The number of mitotic bodies was
reduced (9+0.748 per 100 nuclei) in stroma of
treated animals as compared to that of the control
(23+1.122 per 100 nuclei) (Figure 2g and h).
The number of mitotic ﬁgures in luminal epithe-
lium, glandular epithelium and stroma of cross
sections of uterine horn from the control animals
were found to be signiﬁcantly higher as compared to
that of treated animals (P50.05).
Day-4.5 of pregnancy. The cross sections of uterus
from LPS treated animals showed hyperplasic
luminal and glandular epithelium. The mitotic
ﬁgures were neither observed in luminal epithelium
nor in glandular epithelium of the control and LPS
treated animals. However, lumen closure was ob-
served in uterine sections from the control and LPS
Figure 2. Cross sections of uterine horns from control animals and
animals treated with the ‘minimum dose’ of LPS on day 0.5 of
pregnancy. Note macrophages (closed arrow heads), mitotic
bodies (open arrow heads), necrosis (closed arrow), hyperplasia
(open arrow heads), stroma (S), luminal epithelium (LE),
glandular epithelium (GE), myometrium (M) and uterine lumen
(UL). Panels (a), (c), (e), (g) and (i) – show cross sections of
uterine horns from control animals on days 0.5, 1.5, 2.5, 3.5 and
4.5 of pregnancy, respectively. Panels (b), (d), (f), (h) and (j) –
show cross sections of uterine horns on days 0.5, 1.5, 2.5, 3.5 and
4.5 of pregnancy, respectively, from animals treated with the
‘minimum dose’ of LPS X100.
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same in stroma of uterine cross sections from the
control and LPS treated animals (4+0.374/100
nuclei) (Figure 1a, b and c). A larger number of
leukocytes were observed in stroma of LPS treated
animal as compared to that of the control (Figure 2i
and j).
A signiﬁcant difference in the pattern of mitosis
was observed in luminal epithelium and stroma of
uterine cross sections from LPS treated animals as
compared to that of the control (P50.001). More-
over, a signiﬁcant modulation in the pattern of
mitosis in luminal epithelium and stroma of uterine
cross sections of control and LPS treated animals
was observed with increase in length of gestational
period (P50.001, Figure 1a, b and c).
Effect of LPS on expression of IL-1b in embryos collected
at different stages of preimplantation period of pregnancy
An average of 29+5 embryos per pregnant animal
were collected after superovulation. In the present
study, 500 embryos recovered during different stages
of the preimplantation period (i.e., days-1.5, 2.5, 3.5,
4.0, 4.125, 4.33, & 4.42) of pregnancy from control
and LPS treated animals were used at each time to
study the expression of IL-1b by RT-PCR. The
expression of b-actin gene was used as an internal
standard throughout the experiments. Positive
mRNA signal of IL-1b was observed in embryos
harvested from day-4 of gestation till implantation in
control animals (Figure 3a). However, its expression
was observed (from day-1.5 to 4.42) of pregnancy in
the embryos collected from LPS treated animals
(Figure 3b). A uniform expression of b-actin gene
was observed in the embryos collected from control
and LPS treated animals during different develop-
mental stages of preimplantation period pregnancy
(Figure 3c).
Effect of LPS on expression of IL-1b in uterine horns
collected from different stages of preimplantation period of
pregnancy
The uterine horns collected from control and LPS
treated animals during different stages of preimplan-
tation period of pregnancy (i.e., days-1.5, 2.5, 3.5,
4.0, 4.125, 4.33 and 4.42 of pregnancy) were used to
study the expression of the proinﬂammatory cytokine
IL-1b, by RT-PCR. The expression of b-actin gene
was used as internal standard throughout the
experiments. Positive mRNA signals for IL-1b were
observed from day-1.5 of pregnancy till implantation
in uterus collected from both the groups of animals.
Its expression gradually increased from day 1.5 to
4.42 of pregnancy in uterus collected from both the
groups of animals. However, it was expressed more
in the uterus collected from LPS treated animals as
compared to that of the control as period of
pregnancy approached to stage of implantation
(Figure 4a, b). A uniform expression of b-actin gene
was obtained in the uterus collected from control
and LPS treated animals during different develop-
mental stages of pregnancy (Figure 4c).
Discussion
Endotoxins derived from Gram-negative bacteria
may extensively damage preimplantation stage em-
bryos, decrease rate of embryo cleavage, blastocyst
formation and pregnancy in human [23]. The
biological effects of LPS are largely mediated by
the proinﬂammatory cytokines (e.g., IL-1, IL-6,
TNF, etc.) [24,25]. Several cytokines have been
Figure 3. Detection of IL-1b mRNA transcripts in the pre-
implantation mouse embryos collected from (a) control animals,
(b) animals treated with LPS at the different stages of preimplan-
tation period of pregnancy by RT-PCR. Panel (c) shows the
uniform expression of b-actin used as a positive control.
Figure 4. Detection of IL-1b mRNA transcripts in the uterus of (a)
control animals, (b) animals treated with the ‘minimum dose’ of
LPS at the different stages of preimplantation period of pregnancy
by RT-PCR. Panel (c) shows the expression of b-actin used as a
positive control.
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exist within the feto-maternal interface [26].
The present observation about the pattern of
mitosis, in the uterus of preimplantation period of
pregnancy in the control pregnant animals is similar
to that of an earlier report [27]. However, the
number of mitotic bodies and their pattern was
altered in the uterus of LPS treated animals as
compared to that of the control animals (Figure 1a, b
and c). We observed a proliferative switch from
epithelial to stromal compartments in the uterus of
control animals on day 3 of pregnancy. However,
such observations are not made from the LPS treated
animals and, moreover, the stroma showed a very
low count of the mitotic ﬁgures. The timing of such
cellular changes depends on the hormonal regimens
to which the uterus is exposed. Progesterone is the
primary hormone in conditioning the stromal cells to
divide but in rat and mouse its further exposure to
estradiol is also required [28]. A delay in stromal
mitosis in response to LPS may also delay or prevent
implantation and abolishes the sensitivity of the
uterus to decidual stimuli in mouse [29].
The Interleukin-1 (IL-1) system (IL-1a, IL-1b,
and IL-1R) has previously been shown to play an
important role in the development of murine
preimplantation embryos [26]. IL-1b is expressed at
the time of implantation in the embryos obtained
from the control pregnant animals. Our observations
on the pattern of expression of IL-1b in the embryos
recovered from the control animals during the
preimplantation period of pregnancy are supported
by previous reports [13,11]. In a previous study, we
have shown that IL-1a is expressed only during the
early stages of development [18]. The embryonic
expressions of either of the two forms of IL-1 through
out the preimplantation period of pregnancy may be
necessary to ensure a uninterrupted and upregulated
expression of the b3 integrins and various other genes
necessary to maintain the uterus in a receptive state.
The expression of secretory IL-1b in the preimplan-
tation embryos recovered from control animals from
day-4 of pregnancy till implantation may be required
for signaling the uterus for stromal cell proliferation
and decidualization. However, LPS induced early
expression of IL-1b (i.e., from day 1.5 of pregnancy
till implantation) in the embryos may disrupt the feto-
maternal signaling mechanisms required for success-
ful implantation. The altered pattern of expression of
interleukin-1 beta in the embryos in response to LPS
may have autocrine and paracrine effects that may be
detrimental to the embryonic development, which
may alter the uterine receptivity for the implanting
blastocyst and may contribute to embryonic losses in
mouse.
In a previous study the expression of IL-1 receptor
was not detected in the embryos of mouse at any of
the stage of preimplantation period of pregnancy,
however, the expression of IL-1RI was observed in
the uterus of pregnant animals during this stage of
pregnancy [11]. This result indicates that the
embryos at the early stages of preimplantation period
of pregnancy may not be capable of responding to
IL-1 forms, however, it may potentially signal the
maternal endometrium through the IL-1RI. The
altered pattern of expression of different forms of
embryonic IL-1 gene and LPS molecule itself may
initiate a cascade of additional proinﬂammatory
substances in the LPS treated animals (e.g., TNF,
IL-6, and IL-8), which may contribute to infection-
mediated pregnancy losses [30,31] in mice.
In the present study, we found that IL-1b is
expressed in uterus throughout the preimplantation
period of pregnancy. IL-1a and IL-1b are produced
by decidual cells in response to LPS and are present
in the amniotic ﬂuid of women with preterm labor
and intraamniotic infection [32]. It has been
reported that the exogeneously administered IL-1a
can cause fetal death and in some cases abortion in
pregnant mice [33,18]. We observed a similarity in
the pattern of expression of IL-1a and IL-1b in the
uterus of control animals.
Silver et al. (1997) [34] reported that lipopolysac-
charide-induced fetal death is a prostaglandin–
independent effect. Dudley et al. (1993) [35]
observed that IL-1b and LPS signiﬁcantly increases
the production of PGE2 and IL-6 from murine
decidua. We observed an increase in expression of
IL-1b gene in the uterus of LPS treated animals
throughout the preimplantation period of pregnancy
as compared to that of the respective controls. The
elevated levels of IL-1b may trigger the production of
prostaglandins and other cytokines (e.g., TNF, IL-6,
and IL-8) by the gestational tissues, leading to
pregnancy loss.
The altered pattern of expression of both of the
forms of IL-1 in embryos and its upregulation in
uterus during the preimplantation period of preg-
nancy in response to LPS may stimulate the
expression of COX-2 gene and the synthesis of
PGE2 in the endometrial stromal and epithelial cells
[36,37]. Psychoyos et al. (1973) [38] suggested that
PG-mediated inﬂammatory reaction in the endome-
trium in response to the implanting embryo is
necessary for implantation. Jacobs et al. (1994)
[39] reported that newly differentiated luminal
epithelial cells at the implantation site express
COX-2. The regulation of the expression of COX-
2 gene is the key control of PG-synthesis and any
alterations in the level of COX-2 may lead to an
alteration in the biosynthesis of PGE2. Thus, a
controlled expression of IL-1 in embryonic
and uterine tissue may be essential for the success-
ful implantation of embryos in mouse and any
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of this cytokine in response to LPS may lead to
failure of implantation through a PG-dependent
pathway.
Altered IL-1b expression in the preimplantation
embryos and uterine horns by the ‘minimum dose’ of
LPS may be responsible for poor embryonic devel-
opment and also may cause a poor uterine
preparation for implantation, by altering the expres-
sion of other developmentally important cytokines
and growth factors. This might also disturb the
process of decidualization as observed in our
histopathological studies. Therefore, LPS induced
implantation failure in mice could be due to poor
embryonic development and improper preparation of
the uterine horns for receiving the embryo.
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